Endologix (ELGX) Misses Q3 EPS by 3c

Endologix (NASDAQ: ELGX) reported Q3 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $52.1 million versus the consensus estimate of $51.83 million.

GUIDANCE:

Endologix sees FY2016 revenue of $198-201 million, versus the consensus of $202 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.

You May Also Be Interested In

• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Walmart shares fall despite earnings beat